SION: Sionna Therapeutics, Inc.
Performance
SION -89.71%
Watchlist
Select an item
Summary
SION at a glance
SION returned -89.71% over the past year. Its worst drop in that year was -93.57%, smaller than 0% of stocks on Redstone, and its Sharpe ratio of -0.39 beats 14% of stocks on Redstone. It pays no dividends.
Current Drawdown
-93.01%
Rolling Volatility
76.92%
Actions
Metrics
Risk Indicators
Alpha-62.71%
Beta1.60x
Sharpe-0.39
Sortino-0.44
Omega0.91
Calmar-0.96
Martin-1.01
Profile
About SION
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $161M
- Listed
- Feb 2025
- Employees
- 59
- Headquarters
- Waltham, MA
- Website
- sionnatx.com
Comparisons